Navigation Links
Aarhus University to inaugurate the ultimate source of light:
Date:9/10/2012

ASTRID2 will be one of the world's ultimate sources of x-ray. The 46 meters long ring will have applications in a broad spectre of scientific areas, and will in the future offer possibilities to, for instance, test new medication or play a key role in the research of new and exotic materials, which can contribute to society's technological development.

Physicists at Institute of Physics and Astronomy has worked on the accelerator since 2008, where the Danish Ministry of Science granted approx. 5 million Euro to the construction of the new accelerator. Today it is a proud Head of Centre that can present the outcome of their work:

"Only very few places in the world will be able to offer facilities like the one we inaugurate today in Denmark. In the wavelength area in which ASTRID2 will operate, Aarhus University will now be placed as one of the worlds leading facilities. We will be able to offer the international scientific elite the ultimate source of synchrotron radiation," says Head of Institute of Storage Ring Facilities, Aarhus University, Sren Pape Mller.

ASTRID2 accelerates particles to just below the speed of light, whereby very intense shortwave light is produced. This brilliant light, the synchrotron radiation, is used by scientists to analyse everything from biological systems to to nano technological connections on atomic scale.

In 1991 Aarhus University became the only Danish university with a large particle accelerator of this type, when the first ASTRID was inaugurated. In the 21 years that have passed since, the research team has created a world leading scientific environment at the university campus. Aarhus University still has the only research centre for particle acceleration with high technological equipment at its disposal in Denmark not only for research, but for education of future scientists as well.

Through the years, ASTRID has been used by a wide variety of international researchers; doctors, physicists and biologists and they have been able to reveal physiological properties that have never been seen before.

Like its predecessor, ASTRID2 will play a vital role in areas like autoimmune illness and in the R&D of future materials like graphen. The step from the old ring to the new one will enable a whole new level of detail and possibilities, explains Sren Pape Mller: "The step we take here can resemble the technological step that mankind took, when we went from hammer and anvil to nanophysics."

According to Sren Pape Mller, the accelerator and the accumulated expertize at Aarhus University can be transferred to other life important areas of health research:

"With our knowledge regarding the construction and development of accelerators like ASTRID2, we will be an essential partner in the R&D of radiation therapy and treatment of cancer patients."

The expectations to the interdisciplinary research at Aarhus University are high. The university has recently employed two international renowned scientists in the fields of medicine and physics, which will strengthen the Danish research in advanced radiation treatment of cancer patients.


'/>"/>
Contact: Sren Pape Mller
fyssp@phys.au.dk
45-23-38-23-42
Aarhus University
Source:Eurekalert

Related medicine news :

1. Multi-functional anti-inflammatory/anti-allergic developed by Hebrew University researcher
2. University of Hawaii cancer researchers discover gene defect responsible for cancer syndrome
3. Oxford University Press acquires American Journal of Hypertension
4. Queens University Belfast wins national environment award
5. Non-invasive treatment for children with obstructive sleep apnea suggested by Ben-Gurion University study
6. University of Colorado Cancer Center earns major grant to develop new bladder cancer drugs
7. Hospital of the University of Pennsylvania selected to lead US nurse-training initiative
8. University of Pennsylvania and Novartis form alliance to expand use of personalized T cell cancer therapy
9. Boston University researchers expand synthetic biologys toolkit
10. Canadians super-sizing Canadas Food Guide servings: York University study
11. Tel Aviv University researcher says plants can see, smell, feel, and taste
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination ... are complicated and require expert user knowledge. In a live webinar on April ... the simplified, yet highly accurate, determination of sodium. , It has long been ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle Emergency Center ... Monday, April 3rd to commemorate the two-year anniversary of the facility. The event ... celebrate two great years while also familiarizing themselves with the facility. , In ...
(Date:3/27/2017)... , ... March 27, 2017 , ... Harris Communications, Inc., ... hearing, is bringing its latest products to the Deaf Seniors of America Conference, April ... the opportunity to meet with knowledgeable ASL friendly staff from Harris Communications and to ...
(Date:3/25/2017)... Wisconsin (PRWEB) , ... March 25, 2017 , ... Norland at Swissray is ... composition analyzers for large subjects. The ELITE DXA has an active scan window, which ... wide or long to fit in the scan area could not undergo an accurate total ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... will spark a conversation on the current obstacles facing infection prevention and offer ... preventable deaths caused by these infections. , The print component of “Fighting ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... FRANCISCO , March 27, 2017  Twist Bioscience, ... DNA synthesis, today announced that it raised an additional ... total of $166 million. "It is ... we expand our reach and continue to deliver industry-leading ... multiple market segments," commented Emily M. Leproust, Ph.D., CEO ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. (NASDAQ: ... life-threatening inherited liver diseases in children, today reported ... year ended December 31, 2016 and provided an ... "PhaseRx continued to make progress during the fourth ... results from our non-human primate safety study, and with ...
(Date:3/27/2017)... 2017 Invivotek, LLC, a Genesis Biotechnology Group ... pharmacology contract research organization (CRO), announced the completion ... expanded preclinical research facility in Hamilton, New ... renewable energy source to reduce costs and lessen the ... Genesis Solar Farm follows Invivotek,s recent expansion from a ...
Breaking Medicine Technology: